Synthetic Triacylated Lipopeptide (VAdv-Ly0036)
Synthetic triacylated lipopeptide, a synthetic lipopeptide and a TLR2/1 agonist vaccine adjuvant.
Specificity
TLR1/2 agonist
Percentage
≥ 95% by UHPLC
Endotoxin
Lower than 1 EU/mg.
Introduction
Synthetic triacylated lipopeptides are potent immune adjuvants that mimic the structure of bacterial lipopeptides, key components of microbial cell walls. These synthetic molecules are designed to activate the innate immune system by engaging Toll-like receptor 2 (TLR2), often in cooperation with TLR1. This activation triggers a signaling cascade that leads to the production of pro-inflammatory cytokines, effectively enhancing the adaptive immune response to co-administered antigens.
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.